Veracyte Newsroom

Veracyte's Strong Q1 Performance and Upbeat Outlook Justify Buy Rating

TipRanksMay 10 04:41 ET

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT) and Argenx Se (ARGX)

TipRanksMay 10 04:35 ET

Veracyte Analyst Ratings

BenzingaMay 8 08:17 ET

Needham Maintains Buy on Veracyte, Lowers Price Target to $27

BenzingaMay 8 08:16 ET

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Veracyte (VCYT) and Nevro Corp (NVRO)

TipRanksMay 8 07:28 ET

Veracyte Analyst Ratings

BenzingaApr 15 10:34 ET

Analysts' Top Healthcare Picks: BioCryst (BCRX), Veracyte (VCYT)

TipRanksFeb 27 07:11 ET

Veracyte Analyst Ratings

BenzingaFeb 26 11:15 ET

Analysts Are Bullish on Top Healthcare Stocks: Veracyte (VCYT), Irhythm Technologies (IRTC)

TipRanksFeb 23 05:40 ET

Veracyte Analyst Ratings

BenzingaFeb 23 05:33 ET

Buy Rating Affirmed for Veracyte Amid Strong Financials and Strategic MRD Market Acquisition

TipRanksJan 11 01:26 ET

Solid Growth and Strategic Acquisition Bolster Buy Rating for Veracyte

TipRanksJan 8 12:16 ET

Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $22

BenzingaNov 10, 2023 09:26 ET

Veracyte Analyst Ratings

BenzingaNov 10, 2023 09:25 ET

Veracyte's Strategic Moves and Robust Performance Drive Buy Rating: An Analysis of Key Factors

TipRanksNov 10, 2023 06:20 ET

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Jazz Pharmaceuticals (JAZZ) and Tenaya Therapeutics (TNYA)

TipRanksNov 9, 2023 12:48 ET

Needham Maintains Buy on Veracyte, Lowers Price Target to $30

BenzingaNov 8, 2023 17:02 ET

Veracyte Analyst Ratings

BenzingaNov 8, 2023 17:01 ET

Goldman Sachs Maintains Buy on Veracyte, Lowers Price Target to $32

BenzingaOct 23, 2023 09:07 ET

Veracyte Analyst Ratings

BenzingaOct 23, 2023 09:06 ET